EUVIMEDEUVIMED entdecken
Vergleichsstudie

Glioma Tumor Grading Using Radiomics on Conventional MRI : A Comparative Study of WHO 2021 and WHO 2016 Classification of Central Nervous Tumors

Farzan Moodi iD, Fereshteh Khodadadi Shoushtari iD, Delaram J Ghadimi iD, Gelareh Valizadeh, Ehsan Khormali, Hanieh Mobarak Salari, Mohammad Amin Dabbagh Ohadi, Yalda Nilipour, Amin Jahanbakhshi, Hamidreza Saligheh Rad iD

Journal of Magnetic Resonance Imaging · 2024

DOI: 10.1002/jmri.29146 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Magnetic Resonance Imaging, 2024. Verfasst von Farzan Moodi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Quantitative MR Imaging and Spectroscopy Group (QMISG), Tehran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Glioma, Neoplasm Grading, Magnetic Resonance Imaging, World Health Organization. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Institute for Medical Research Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Glioma grading transformed in World Health Organization (WHO) 2021 CNS tumor classification, integrating molecular markers. However, the impact of this change on radiomics‐based machine learning (ML) classifiers remains unexplored.

Purpose

To assess the performance of ML in classifying glioma tumor grades based on various WHO criteria. Study Type Retrospective. Subjects A neuropathologist regraded gliomas of 237 patients into WHO 2016 and 2021 from 2007 criteria. Field Strength/Sequence Multicentric 0.5 to 3 Tesla; pre‐ and post‐contrast T1‐weighted, T2‐weighted, and fluid‐attenuated inversion recovery. Assessment Radiomic features were selected using random forest‐recursive feature elimination. The synthetic minority over‐sampling technique (SMOTE) was implemented for data augmentation. Stratified 10‐fold cross‐validation with and without SMOTE was used to evaluate 11 classifiers for 3‐grade (2, 3, and 4; WHO 2016 and 2021) and 2‐grade (low and high grade; WHO 2007 and 2021) classification. Additionally, we developed the models on data randomly divided into training and test sets (mixed‐data analysis), or data divided based on the centers (independent‐data analysis). Statistical Tests We assessed ML classifiers using sensitivity, specificity, accuracy, and the area under the receiver operating characteristic curve (AUC). Top performances were compared with a t ‐test and categorical data with the chi‐square test using a significance level of P < 0.05.

Results

In the mixed‐data analysis, Stacking Classifier without SMOTE achieved the highest accuracy (0.86) and AUC (0.92) in 3‐grade WHO 2021 grouping. The results of WHO 2021 were significantly better than WHO 2016 ( P ‐value

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaNeoplasm GradingMagnetic Resonance ImagingWorld Health OrganizationMachine LearningHumansRetrospective StudiesMaleFemaleMiddle AgedAdultAgedBrain NeoplasmsReproducibility of ResultsCentral Nervous System NeoplasmsROC CurveImage Processing, Computer-AssistedRadiomics

Stichwörter der Autor:innen

WHO CNS tumor classificationartificial intelligencegliomamachine learningneoplasm gradingradiomics

Autor:innen und Institutionen

  • Quantitative MR Imaging and Spectroscopy Group (QMISG), Tehran University of Medical Sciences, Tehran, Iran.
  • School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
  • School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Student Research Committee, School of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
  • Interdisciplinary Neuroscience Research Program, Tehran University of Medical Sciences, Tehran, Iran.
  • Departments of Pediatric Neurosurgery Children's Medical Center Hospital, Tehran University of Medical Sciences, Tehran, Iran.

ORCID-Profile: Farzan Moodi, Fereshteh Khodadadi Shoushtari, Delaram J Ghadimi, Hamidreza Saligheh Rad

Förderung

  • National Institute for Medical Research Development

Zitieren

APA

Moodi, F., Khodadadi Shoushtari, F., Ghadimi, D. J., Valizadeh, G., Khormali, E., Salari, H. M., Ohadi, M. A. D., Nilipour, Y., Jahanbakhshi, A., & Rad, H. S. (2024). Glioma Tumor Grading Using Radiomics on Conventional MRI : A Comparative Study of WHO 2021 and WHO 2016 Classification of Central Nervous Tumors. Journal of Magnetic Resonance Imaging. https://doi.org/10.1002/jmri.29146

Vancouver

Moodi F, Khodadadi Shoushtari F, Ghadimi DJ, Valizadeh G, Khormali E, Salari HM, et al. Glioma Tumor Grading Using Radiomics on Conventional MRI : A Comparative Study of WHO 2021 and WHO 2016 Classification of Central Nervous Tumors. Journal of Magnetic Resonance Imaging. 2024. doi:10.1002/jmri.29146

BibTeX
@article{Moodi2024,
  author = {Moodi, Farzan and Khodadadi Shoushtari, Fereshteh and Ghadimi, Delaram J and Valizadeh, Gelareh and Khormali, Ehsan and Salari, Hanieh Mobarak and Ohadi, Mohammad Amin Dabbagh and Nilipour, Yalda and Jahanbakhshi, Amin and Rad, Hamidreza Saligheh},
  title = {Glioma Tumor Grading Using Radiomics on Conventional MRI : A Comparative Study of WHO 2021 and WHO 2016 Classification of Central Nervous Tumors},
  journal = {Journal of Magnetic Resonance Imaging},
  year = {2024},
  doi = {10.1002/jmri.29146}
}
Kostenlos starten →